United Therapeutics Corporation at Morgan Stanley Global Healthcare Conference Transcript
All right. Well, thanks so much for joining us, everybody. I'm Terence Flynn, Morgan Stanley's US biopharma analyst.
For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
I'm very pleased to be hosting United Therapeutics this afternoon. Joining us from the company, we have Martine Rothblatt, who is the company's Chairperson and CEO; and Pat Poisson, who is EVP, Strategic Development. Thank you both so much for taking time out of your day to join us. Really appreciate it, and looking forward to the conversation.
Maybe Martine, first, I'll just turn it over to you to maybe make some framing comments before I launch into my questions, but thanks so much.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
